US approves new treatment for pancreatic cancer
The US Food and Drug Administration announced its approval for a drug that could double the survival time of some patients for a type of cancer that has, historically, been difficult to treat.
We haven't written up this one. Le Monde English has the full story — the link below goes straight to it.